Home/Filings/4/0001209191-22-031366
4//SEC Filing

Reddoch James F. 4

Accession 0001209191-22-031366

CIK 0001802768other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:57 PM ET

Size

5.9 KB

Accession

0001209191-22-031366

Insider Transaction Report

Form 4
Period: 2022-05-19
Reddoch James F.
EVP, Research & Investments
Transactions
  • Sale

    Class A Ordinary Shares

    2022-05-19$40.44/sh75,000$3,033,1281,095,800 total(indirect: By LLC)
Holdings
  • Class A Ordinary Shares

    (indirect: By IRA)
    25,030
Footnotes (1)
  • [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.35 to $40.60 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Royalty Pharma plc

CIK 0001802768

Entity typeother

Related Parties

1
  • filerCIK 0001814872

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:57 PM ET
Size
5.9 KB